Insmed
INSM
INSM
237 hedge funds and large institutions have $2.78B invested in Insmed in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 93 increasing their positions, 60 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $2.54B → $2.78B (+$247M)
0.76% more ownership
Funds ownership: 108.09% → 108.85% (+0.76%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
237
Holding in Top 10
3
Calls
$6.73M
Puts
$4.93M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$10.8M | |
| 3 | +$9.48M | |
| 4 |
Goldman Sachs
New York
|
+$8.67M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$8.29M |
Top Sellers
| 1 | -$144M | |
| 2 | -$46M | |
| 3 | -$25.4M | |
| 4 |
Holocene Advisors
New York
|
-$25.1M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$18.3M |